AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

AGILENT TECHNOLOGIES, INC.

Regulatory Filings Mar 17, 2022

Preview not available for this file type.

Download Source File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 16, 2022

AGILENT TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Delaware 001-15405 77-0518772
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
5301 Stevens Creek Boulevard , Santa Clara, CA 95051
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (800) 227-9770

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.01 Par Value A New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders

The Annual Meeting of Stockholders of the Company was held on March 16, 2022 (the “Annual Meeting”). A total of 266,837,916 shares of Common Stock, representing approximately 88.84% of the shares outstanding, were represented at the Annual Meeting. The voting results for each item of business presented at the Annual Meeting, as certified by the Company’s independent inspector of elections, are set forth below:

Proposal No. 1 The election of three (3) directors for a term of three years. The individuals listed below received the affirmative vote of a majority of the votes cast by the shares present in person or represented by proxy and entitled to vote at the Annual Meeting and were each elected to serve a three-year term.

Name For Against Abstain Broker Non-Vote
Hans E. Bishop 219,566,395 26,056,611 444,401 20,770,508
Otis W. Brawley, M.D. 241,120,057 4,497,367 449,983 20,770,508
Mikael Dolsten, M.D., Ph.D. 234,934,495 10,673,089 459,823 20,770,508

Directors Mala Anand, Koh Boon Hwee, Heidi Kunz, Michael R. McMullen, Daniel K. Podolsky, M.D., Sue H. Rataj, George A. Scangos, Ph.D. and Dow R. Wilson continued in office following the Annual Meeting.

Proposal No. 2 The non-binding advisory vote to approve the compensation of the Company’s named executive officers was approved as set forth below.

For Against Abstain Broker Non-Vote
216,898,569 28,651,613 517,124 20,770,508

Proposal No. 3 The proposal to ratify the Audit and Finance Committee’s appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2022 fiscal year was approved as set forth below.

For Against Abstain Broker Non-Vote (1)
248,388,336 17,949,546 500,033 -0-

Proposal No. 4 The stockholder proposal regarding the right to call a special meeting was approved as set forth below.

For Against Abstain Broker Non-Vote (1)
200,652,664 44,840,290 574,270 20,770,508

(1) Pursuant to the rules of the New York Stock Exchange, this proposal constituted a routine matter. Therefore, brokers were permitted to vote without receipt of instructions from beneficial owners.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

By: /s/P. Diana Chiu
Name: P. Diana Chiu
Title: Vice President, Assistant General Counsel & Assistant Secretary
Date: March 17, 2022

Talk to a Data Expert

Have a question? We'll get back to you promptly.